Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study.
Hormazábal J, Nuñez-Franz L, Rubilar P, Apablaza M, Vial C, Cortés LJ, González N, Vial P, Said M, González C, Olivares K, Aguilera X, Ramírez-Santana M. Hormazábal J, et al. Among authors: cortes lj. Vaccine X. 2023 Aug 26;15:100372. doi: 10.1016/j.jvacx.2023.100372. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37693843 Free PMC article.
Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020-2022.
Núñez-Franz L, Ramírez-Santana M, Rubilar P, Vial C, Apablaza M, González C, Said M, Olivares K, Cortés LJ, Hormazábal J, Canales L, Vial P, Icaza G, Quezada-Gaete R, Aguilera X. Núñez-Franz L, et al. Among authors: cortes lj. Viruses. 2023 Jan 10;15(1):201. doi: 10.3390/v15010201. Viruses. 2023. PMID: 36680241 Free PMC article.
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes.
Aguilera X, Hormazábal J, Vial C, Cortes LJ, González C, Rubilar P, Apablaza M, Ramírez-Santana M, Icaza G, Nuñez-Franz L, Castillo-Laborde C, Ramírez-Riffo C, Pérez C, Quezada-Gate R, Said M, Vial P. Aguilera X, et al. Among authors: cortes lj. Vaccines (Basel). 2022 Jun 30;10(7):1051. doi: 10.3390/vaccines10071051. Vaccines (Basel). 2022. PMID: 35891215 Free PMC article.
Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile.
Aguilera X, González C, Apablaza M, Rubilar P, Icaza G, Ramírez-Santana M, Pérez C, Cortes LJ, Núñez-Franz L, Quezada-Gaete R, Castillo-Laborde C, Correa J, Said M, Hormazábal J, Vial C, Vial P. Aguilera X, et al. Among authors: cortes lj. Vaccines (Basel). 2022 Jun 23;10(7):1002. doi: 10.3390/vaccines10071002. Vaccines (Basel). 2022. PMID: 35891166 Free PMC article.
Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group.
Escobar A, Reyes-López FE, Acevedo ML, Alonso-Palomares L, Valiente-Echeverría F, Soto-Rifo R, Portillo H, Gatica J, Flores I, Nova-Lamperti E, Barrera-Avalos C, Bono MR, Vargas L, Simon V, Leiva-Salcedo E, Vial C, Hormazabal J, Cortes LJ, Valdés D, Sandino AM, Imarai M, Acuña-Castillo C. Escobar A, et al. Among authors: cortes lj. Front Immunol. 2022 Jan 31;12:766278. doi: 10.3389/fimmu.2021.766278. eCollection 2021. Front Immunol. 2022. PMID: 35173705 Free PMC article.
20 results